Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-09-18 18:00:03 ET · period of report 2026-09-16 · accession 0001800668-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-18 18:00 | 2026-09-16 | RVMD | Anders Jack | CFO | S - Sale | $199.24 | -4,053 | 119.2K | -3% | -$807.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-16 | S | D | 61 | $195.00 | 123,208 | D | — | — | (F1) Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2026-09-16 | S | D | 3,992 | $199.30 | 119,216 | D | — | — | (F1) Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units. (F2) Includes 43,650 restricted stock units. |